The so far well-received new name and redefinition of fatty liver disease have generated debates. The most common argument is that there is no consensus on any name change. A craft group was created to identify and refine methods of consensus building in hepatology.
Y. Fouad, et al. (Minia University, Egypt) “believe that the time has come for redirecting stakeholder focus and energy on capitalising on the momentum generated by the debate to improve the lives of people at its centre, our patients.”